These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31373046)

  • 21. Image Gallery: Kaposiform haemangioendothelioma.
    Moscarella E; Ametrano O; Diplomatico M; De Chiara C; Capasso M; Errico ME; Picciocchi R
    Br J Dermatol; 2017 Jun; 176(6):e124. PubMed ID: 28581217
    [No Abstract]   [Full Text] [Related]  

  • 22. An intermediate vascular tumour between kaposiform hemangioendothelioma and tufted angioma with regression of the skin lesion.
    Makino T; Ishida W; Hamashima T; Mizawa M; Sasahara M; Shimizu T
    Eur J Dermatol; 2017 Apr; 27(2):175-176. PubMed ID: 27882874
    [No Abstract]   [Full Text] [Related]  

  • 23. Kaposiform Hemangioendothelioma Presenting as Hydrops Fetalis.
    Sobrino-Fernández E; Campos-Domínguez M; Gregorio-Hernández R; Huerta-Aragonés J; Beléndez-Bieler C; Lancharro-Zapata Á; Franco-Fernández ML; Bernardo-Atienza B; Sánchez-Luna M
    Pediatr Dermatol; 2017 May; 34(3):e128-e129. PubMed ID: 28318049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical spectrum of kaposiform hemangioendothelioma and tufted angioma.
    Croteau SE; Gupta D
    Semin Cutan Med Surg; 2016 Sep; 35(3):147-52. PubMed ID: 27607323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kaposiform hemangioendothelioma and tufted angioma: two entities of the same clinicopathological spectrum.
    Nieto-Benito LM; Huerta-Aragonés J; Parra-Blanco V; Campos-Domínguez M
    An Bras Dermatol; 2023; 98(3):391-394. PubMed ID: 36604299
    [No Abstract]   [Full Text] [Related]  

  • 26. Kaposiform haemangioendothelioma: a review with emphasis on histological differential diagnosis.
    Putra J; Gupta A
    Pathology; 2017 Jun; 49(4):356-362. PubMed ID: 28438388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of Refractory Mandibular Kaposiform Hemangioendothelioma with Sirolimus: A Case Report and Review of the Literature.
    Rikhotso RE; Alharbi AA
    J Oral Maxillofac Surg; 2021 Oct; 79(10):2086.e1-2086.e8. PubMed ID: 34153244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical Analysis of mTOR Pathway-Related Proteins in Kaposiform Hemangioendothelioma.
    Wang Z; Zheng C; Sun H; Yao W; Li K; Ma Y; Zheng S
    Dermatology; 2020; 236(3):262-270. PubMed ID: 31896113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sirolimus therapy for kaposiform hemangioendothelioma with long-term follow-up.
    Wang Z; Yao W; Sun H; Dong K; Ma Y; Chen L; Zheng S; Li K
    J Dermatol; 2019 Nov; 46(11):956-961. PubMed ID: 31489702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of Kaposiform hemangioendothelioma with everolimus.
    Uno T; Ito S; Nakazawa A; Miyazaki O; Mori T; Terashima K
    Pediatr Blood Cancer; 2015 Mar; 62(3):536-8. PubMed ID: 25306933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
    Ji Y; Chen S; Yang K; Xia C; Peng S
    J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and imaging features of Kaposiform Hemangioendothelioma.
    Hu PA; Zhou ZR
    Br J Radiol; 2018 Jun; 91(1086):20170798. PubMed ID: 29536769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular Tumors in Infants: Case Report and Review of Clinical, Histopathologic, and Immunohistochemical Characteristics of Infantile Hemangioma, Pyogenic Granuloma, Noninvoluting Congenital Hemangioma, Tufted Angioma, and Kaposiform Hemangioendothelioma.
    Johnson EF; Davis DM; Tollefson MM; Fritchie K; Gibson LE
    Am J Dermatopathol; 2018 Apr; 40(4):231-239. PubMed ID: 29561329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging findings of Kaposiform Hemangioendothelioma in children.
    Ryu YJ; Choi YH; Cheon JE; Kim WS; Kim IO; Park JE; Kim YJ
    Eur J Radiol; 2017 Jan; 86():198-205. PubMed ID: 28027747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-alpha therapy for refractory kaposiform hemangioendothelioma: a single-center experience.
    Wu HW; Wang X; Zhang L; Zhao HG; Wang YA; Su LX; Fan XD; Zheng JW
    Sci Rep; 2016 Oct; 6():36261. PubMed ID: 27796340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transformation between Kaposiform hemangioendothelioma and tufted angioma.
    Chu CY; Hsiao CH; Chiu HC
    Dermatology; 2003; 206(4):334-7. PubMed ID: 12771476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Refractory Pediatric Kaposiform Hemangioendothelioma With Sirolimus and Aspirin.
    MacFarland SP; Sullivan LM; States LJ; Bailey LC; Balamuth NJ; Womer RB; Olson TS
    J Pediatr Hematol Oncol; 2018 May; 40(4):e239-e242. PubMed ID: 29240034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological features of Kaposiform hemangioendothelioma.
    Liu Q; Jiang L; Wu D; Kan Y; Fu F; Zhang D; Gong Y; Wang Y; Dong C; Kong L
    Int J Clin Exp Pathol; 2015; 8(10):13711-8. PubMed ID: 26722599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kasabach-Merritt syndrome, kaposiform haemangioendothelioma and platelet blockade.
    O'Rafferty C; O'Regan GM; Irvine AD; Smith OP
    Br J Haematol; 2015 Oct; 171(1):11. PubMed ID: 26114338
    [No Abstract]   [Full Text] [Related]  

  • 40. Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy.
    Matsumoto H; Ozeki M; Hori T; Kanda K; Kawamoto N; Nagano A; Azuma E; Miyazaki T; Fukao T
    J Pediatr Hematol Oncol; 2016 Nov; 38(8):e322-e325. PubMed ID: 26907642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.